Recent session action on shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) puts the stock on today’s active list. Since the open, shares have moved 0.55% after recently hitting the $11.65 mark.
Digging a bit further, company shares have been noted -71.71% off the 52 week high and 7.41% away from the 52 week low. Looking at a shorter time period, shares have been seen -42.02% away from the 50 day high and 7.41% off the 50 day low price.
Covering sell-side analysts have recently weighed in on shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA). At the time of writing, the First Call consensus price target for the company is $15.12. The current consensus recommendation provided by covering analysts is 3.00.
This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. A rating of 4 or 5 would represent a Sell recommendation. Analysts giving the company a rating of 3 would be indicating a Hold recommendation.
Since the beginning of the calendar year, the stock is -67.50%. For the quarter, shares have been noted at -31.35%. Share performance for the month is currently at -22.24%. Tightening the gaze, stock performance for the last 5 trading days is 3.33%.